From the *Unité thyroïde, Institut Jean Godinot, Reims; †Service d'endocrinologie, diabétologie, nutrition, ‡Service de chirurgie digestive et endocrinienne, and §Laboratoire d'anatomie et cytologie pathologique, Hôpital Robert Debré, CHU de Reims; ∥Service de médecine nucléaire, Institut Jean Godinot, Reims; ¶Laboratoire de Biophysique, UFR de médecine, Université de Reims Champagne Ardenne; and **CRESTIC EA 3804, Université de Reims Champagne Ardenne.
Clin Nucl Med. 2017 Mar;42(3):218-220. doi: 10.1097/RLU.0000000000001500.
A 73-year-old man displaying primary hyperparathyroidism with severe hypercalcemia (Ca: 4.1 mmol/l, PTH > 600 pmol/l) was referred for preoperative localization of a parathyroid adenoma. Tc-pertechnetate and Tc-sestaMIBI dual tracer scintigraphy displayed a mild focal uptake in the projection of the right thyroid lobe with negative ultrasonography. F-Fluorocholine PET/CT was quickly performed considering this discrepancy and not only confirmed the scintigraphic findings but also revealed a second contralateral focus of increased uptake, both later confirmed by operative consideration (the two other parathyroid glands are considered normal by the surgeon), pathology, and intraoperative parathyroid hormone assessment.
一位 73 岁男性,表现为原发性甲状旁腺功能亢进伴严重高钙血症(Ca:4.1mmol/L,PTH>600pmol/L),因甲状旁腺腺瘤术前定位而就诊。Tc-过锝酸盐和 Tc-sestaMIBI 双示踪剂闪烁扫描显示右甲状腺叶投影处有轻度局灶性摄取,超声检查为阴性。考虑到这种差异,快速进行了 F-氟代胆碱 PET/CT 检查,不仅证实了闪烁扫描的发现,还显示了第二个对侧摄取增加的焦点,这两个焦点后来都通过手术考虑(外科医生认为另外两个甲状旁腺是正常的)、病理和术中甲状旁腺激素评估得到证实。